|
1
|
Neumann E, Schaefer-Ridder M, Wang Y and
Hofschneider PH: Gene transfer into mouse lyoma cells by
electroporation in high electric fields. EMBO J. 1:841–845.
1982.PubMed/NCBI
|
|
2
|
Yarmush ML, Golberg A, Serša G, Kotnik T
and Miklavčič D: Electroporation-based technologies for medicine:
Principles, applications, and challenges. Annu Rev Biomed Eng.
16:295–320. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Golberg A and Yarmush ML: Nonthermal
irreversible electroporation: Fundamentals, applications, and
challenges. IEEE Trans Biomed Eng. 60:707–714. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mir LM, Belehradek M, Domenge C, Orlowski
S, Poddevin B, Belehradek J Jr, Schwaab G, Luboinski B and Paoletti
C: Electrochemotherapy, a new antitumor treatment: First clinical
trial. C R Acad Sci III. 313:613–618. 1991.(In French). PubMed/NCBI
|
|
5
|
Daud AI, DeConti RC, Andrews S, Urbas P,
Riker AI, Sondak VK, Munster PN, Sullivan DM, Ugen KE, Messina JL
and Heller R: Phase I trial of interleukin-12 plasmid
electroporation in patients with metastatic melanoma. J Clin Oncol.
26:5896–5903. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Granot Y and Rubinsky B: Mass transfer
model for drug delivery in tissue cells with reversible
electroporation. Int J Heat Mass Transf. 51:5610–5616. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Otten G, Schaefer M, Doe B, Liu H,
Srivastava I, zur Megede J, O'Hagan D, Donnelly J, Widera G,
Rabussay D, et al: Enhancement of DNA vaccine potency in rhesus
macaques by electroporation. Vaccine. 22:2489–2493. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Davalos RV, Mir IL and Rubinsky B: Tissue
ablation with irreversible electroporation. Ann Biomed Eng.
33:223–231. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pech M, Janitzky A, Wendler JJ, Strang C,
Blaschke S, Dudeck O, Ricke J and Liehr UB: Irreversible
electroporation of renal cell carcinoma: A first-in-man phase I
clinical study. Cardiovasc Intervent Radiol. 34:132–138. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheung W, Kavnoudias H, Roberts S,
Szkandera B, Kemp W and Thomson KR: Irreversible electroporation
for unresectable hepatocellular carcinoma: Initial experience and
review of safety and outcomes. Technol Cancer Res Treat.
12:233–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Martin RC II, McFarland K, Ellis S and
Velanovich V: Irreversible electroporation therapy in the
management of locally advanced pancreatic adenocarcinoma. J Am Coll
Surg. 215:361–369. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Martin RC II, McFarland K, Ellis S and
Velanovich V: Irreversible electroporation in locally advanced
pancreatic cancer: Potential improved overall survival. Ann Surg
Oncol. 20 Suppl 3:S443–S449. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Neal RE II, Millar JL, Kavnoudias H, Royce
P, Rosenfeldt F, Pham A, Smith R, Davalos RV and Thomson KR: In
vivo characterization and numerical simulation of prostate
properties for non-thermal irreversible electroporation ablation.
Prostate. 74:458–468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Golberg A, Bruinsma BG, Uygun BE and
Yarmush ML: Tissue heterogeneity in structure and conductivity
contribute to cell survival during irreversible electroporation
ablation by ‘electric field sinks’. Sci Rep. 5:84852015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ellis TL, Garcia PA, Rossmeisl JH Jr,
Henao-Guerrero N, Robertson J and Davalos RV: Nonthermal
irreversible electroporation for intracranial surgical
applications. Laboratory investigation. J Neurosurg. 114:681–688.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo Y, Zhang Y, Klein R, Nijm GM, Sahakian
AV, Omary RA, Yang GY and Larson AC: Irreversible electroporation
therapy in the liver: Longitudinal efficacy studies in a rat model
of hepatocellular carcinoma. Cancer Res. 70:1555–1563. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Joyce TA, Wong J, Mittra A, Carpenter S,
Haddad D, Carson J, Jayaraman S, Monette S, Solomon SB, Ezell P and
Fong Y: Irreversible electroporation is a surgical ablation
technique that enhances gene transfer. Surgery. 150:474–479. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen L, Wu YY, Liu P, Wang J, Wang G, Qin
J, Zhou J and Zhu J: Down-regulation of HPV18 E6, E7, or VEGF
expression attenuates malignant biological behavior of human
cervical cancer cells. Med Oncol. 28 Suppl 1:S528–S539. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou W, Xiong Z, Liu Y, Yao C and Li C:
Low voltage irreversible electroporation induced apoptosis in HeLa
cells. J Cancer Res Ther. 8:80–85. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rosty C, Sheffer M, Tsafrir D, Stransky N,
Tsafrir I, Peter M, de Crémoux P, de La Rochefordière A, Salmon R,
Dorval T, et al: Identification of a proliferation gene cluster
associated with HPV E6/E7 expression level and viral DNA load in
invasive cervical carcinoma. Oncogene. 24:7094–7104. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Doorbar J: Molecular biology of human
papillomavirus infection and cervical cancer. Clin Sci (Lond).
110:525–541. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Breton M and Mir LM: Microsecond and
nanosecond electric pulses in cancer treatments.
Bioelectromagnetics. 33:106–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang C, Davalos RV and Bischof JC: A
review of basic to clinical studies of irreversible electroporation
therapy. IEEE Trans Biomed Eng. 62:4–20. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Beveridge JR, Wall K, MacGregor SJ,
Anderson JG and Rowan NJ: Pulsed electric field inactivation of
spoilage microorganisms in alcoholic beverages and the influence of
pulse profile. Proc IEEE. 92:pp. 1138–1143. 2004; View Article : Google Scholar
|
|
26
|
Joyce TA, Mittra A, Song TJ, Cavnar M, Jun
K, Carson J, Gholami S, Haddad D, Gaujoux S, Monette S, et al:
Irreversible electroporation facilitates gene transfer of a GM-CSF
plasmid with a local and systemic response. Surgery. 154:496–503.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rubinsky B, Onik G and Mikus P:
Irreversible electroporation: A new ablation modality-clinical
implications. Technol Cancer Res Treat. 6:37–48. 2007. View Article : Google Scholar : PubMed/NCBI
|
